• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolines

Introduction to 3,3-diethyl-2,3-dihydro-1H-indole (CAS No. 130546-01-9)

3,3-diethyl-2,3-dihydro-1H-indole is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its unique structural properties and potential biological activities. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 130546-01-9, belongs to the indole family, which is well-documented for its role in various biological processes and therapeutic applications. The presence of ethyl groups at the 3-position of the indole ring and the dihydro substitution at the 2 and 3 positions contributes to its distinct chemical profile, making it a subject of interest for further exploration in drug discovery and synthetic chemistry.

The structural framework of 3,3-diethyl-2,3-dihydro-1H-indole exhibits a fused bicyclic system consisting of a benzene-like ring connected to a five-membered nitrogen-containing heterocycle. This configuration is reminiscent of many bioactive molecules, particularly those involved in neurotransmitter systems and immunomodulatory pathways. The diethyl substitution at the 3-position enhances the steric bulk of the molecule, which can influence its interactions with biological targets. Such structural features are often exploited in medicinal chemistry to modulate binding affinity and selectivity.

In recent years, there has been growing interest in indole derivatives as potential therapeutic agents due to their diverse biological activities. Studies have suggested that compounds within this chemical class may exhibit properties such as anti-inflammatory, antimicrobial, and even anticancer effects. The specific modifications present in 3,3-diethyl-2,3-dihydro-1H-indole, including the diethyl and dihydro substituents, may contribute to its unique pharmacological profile. For instance, the increased hydrophobicity introduced by the ethyl groups could enhance membrane permeability, facilitating cellular uptake and target engagement.

One of the most compelling aspects of 3,3-diethyl-2,3-dihydro-1H-indole is its potential as a scaffold for further derivatization. Researchers have been exploring various strategies to modify indole-based structures to improve their pharmacokinetic properties and biological efficacy. The dihydro moiety at the 2 and 3 positions provides a site for functionalization that could lead to novel analogs with enhanced activity or selectivity. This flexibility makes 3,3-diethyl-2,3-dihydro-1H-indole a valuable starting point for structure-activity relationship (SAR) studies aimed at identifying more potent and selective drug candidates.

The synthesis of 3,3-diethyl-2,3-dihydro-1H-indole involves multi-step organic transformations that highlight its synthetic accessibility while maintaining high purity standards. The process typically begins with the formation of the indole core through cyclization reactions, followed by selective alkylation to introduce the ethyl groups at the 3-position. The subsequent dihydrolation step at the 2 and 3 positions completes the structural motif. Advances in catalytic methods have enabled more efficient and scalable synthesis routes for this compound, making it more readily available for research purposes.

From a computational chemistry perspective, 3,3-diethyl-2,3-dihydro-1H-indole has been studied using various modeling techniques to predict its interactions with biological targets. Molecular docking simulations have been employed to assess its binding affinity to enzymes and receptors relevant to therapeutic pathways. These studies have provided insights into how structural modifications might influence binding kinetics and thermodynamics. Additionally, quantum mechanical calculations have been used to elucidate electronic properties that could impact reactivity or metabolic stability.

The pharmacological evaluation of 3,3-diethyl-2,3-dihydro-1H-indole has revealed several promising activities in preclinical models. For example, preliminary studies suggest that this compound may exhibit inhibitory effects on certain enzymes implicated in inflammatory responses. The presence of aromatic rings and nitrogen heterocycles often found in indole derivatives is known to interact with heme proteins and other biomolecules involved in redox signaling pathways. Such interactions could underpin its observed biological effects.

In conclusion, 130546-01-9 (CAS No.) represents an intriguing compound with potential applications in pharmaceutical research. Its unique structural features make it a versatile scaffold for developing new therapeutic agents targeting various diseases. As research continues to uncover new biological functions of indole derivatives, 130546-01-9 may play a significant role in advancing drug discovery efforts across multiple therapeutic areas.

• 356073-00-2(3-(piperidin-4-yl)-2,3-dihydro-1H-indole)
• 80278-94-0(1,2,3,3a,4,8b-Hexahydrocyclopentbindole)
• 171-75-5(Spiro[indoline-3,4'-piperidine])
• 13078-91-6(2-(Indolin-3-yl)ethanamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)